Press Releases 06.12.2015
BIND Therapeutics and Macrophage Therapeutics Announce Collaboration to Engineer CD206 Targeted Accurin™ Nanoparticle Using Manocept™ Macrophage Targeting Platform
- Potential for combined Manocept and Accurin platforms to target the tumor microenvironment -